The Critical Role of Preclinical Oral Formulation Selection in Pharmaceutical Safety Assessment
development of poorly soluble or permeable pharmaceutical therapies (Biopharmaceutics Classification System II-IV) has become increasingly common in the pharmaceutical industry. As such, there exists an increasing need

